RISK-FACTORS AND HIV SEROPOSITIVITY AMONG INJECTING DRUG-USERS IN BANGKOK

被引:92
|
作者
CHOOPANYA, K
VANICHSENI, S
JARLAIS, DCD
PLANGSRINGARM, K
SONCHAI, W
CARBALLO, M
FRIEDMANN, P
FRIEDMAN, SR
机构
[1] BETH ISRAEL MED CTR,NARCOT & DRUG RES INST,11 BEACH ST,NEW YORK,NY 10013
[2] BANGKOK METROPOLITAN ADM,DEPT HLTH,BANGKOK,THAILAND
[3] WHO,PROGRAM SUBSTANCE ABUSE,CH-1211 GENEVA 27,SWITZERLAND
关键词
DRUG USE; AIDS; HIV; BANGKOK; INJECTING; THAILAND;
D O I
10.1097/00002030-199112000-00014
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Bangkok experienced an extremely rapid spread of HIV infection among drug injectors in 1987 and 1988. This study examines risk factors for HIV infection and deliberate risk-reduction efforts by drug injectors. Two subsamples of injecting drug users were recruited in November 1989, a group in drug-use treatment (n = 342) and a group new to the treatment system (n = 259). Subjects were interviewed about AIDS risk behavior, and a blood sample was collected for HIV testing. Seroprevalence was 39 and 27% in the in-treatment sample and the new-to-treatment sample, respectively. The in-treatment sample seroprevalence rate is similar to rates observed 6 and 12 months earlier. Three factors were independently associated with HIV infection: subsample, having been in prison, and sharing injection equipment with two or more individuals in the previous 6 months. Deliberate risk reduction was reported by 92% of individuals, with 59% reporting that they had stopped sharing injection equipment. It appears that large-scale risk reduction has greatly slowed HIV transmission among drug injectors in Bangkok.
引用
收藏
页码:1509 / 1513
页数:5
相关论文
共 50 条
  • [31] REGIONAL VARIATIONS IN HIV SEROPREVALENCE AMONG INJECTING DRUG-USERS IN ITALY
    REZZA, G
    REVUE D EPIDEMIOLOGIE ET DE SANTE PUBLIQUE, 1990, 38 (03): : 263 - 264
  • [32] HIV risk reduction in a cohort of injecting drug users in Bangkok, Thailand
    Choopanya, K
    Des Jarlais, DC
    Vanichseni, S
    Mock, PA
    Kitayaporn, F
    Sangkhum, U
    Prasithiphol, B
    Hiranrus, K
    van Griensven, F
    Tappero, JW
    Mastro, ID
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2003, 33 (01) : 88 - 95
  • [33] PREDICTORS OF HIV STATUS AMONG INJECTING DRUG-USERS AND HEALTH PROMOTION
    ROSS, M
    STOWE, A
    WODAK, A
    MILLER, ME
    GOLD, J
    JOURNAL OF THE ROYAL SOCIETY OF HEALTH, 1994, 114 (02): : 75 - 80
  • [34] SEXUAL PARTNERS OF INJECTING DRUG-USERS - THE RISK OF HIV-INFECTION
    KLEE, H
    FAUGIER, J
    HAYES, C
    BOULTON, T
    MORRIS, J
    BRITISH JOURNAL OF ADDICTION, 1990, 85 (03): : 413 - 418
  • [35] THE HARM REDUCTION APPROACH AND RISK-FACTORS FOR HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) SEROCONVERSION IN INJECTING DRUG-USERS, AMSTERDAM - REPLY
    VANAMEIJDEN, EJC
    VANDENHOEK, JAR
    VANHAASTRECHT, HJA
    COUTINHO, RA
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1993, 138 (09) : 769 - 771
  • [36] MOBILITY OF SCOTTISH INJECTING DRUG-USERS AND RISK OF HIV-INFECTION
    GOLDBERG, DJ
    FRISCHER, M
    TAYLOR, A
    GREEN, ST
    MCKEGANEY, N
    BLOOR, M
    REID, D
    COSSAR, J
    EUROPEAN JOURNAL OF EPIDEMIOLOGY, 1994, 10 (04) : 387 - 392
  • [38] PREVALENCE OF INJECTING DRUG-USE PROVIDES THE CONTEXT FOR EPIDEMIOLOGY OF HIV AMONG INJECTING DRUG-USERS
    FRISCHER, M
    GREEN, S
    GOLDBERG, D
    AIDS, 1993, 7 (03) : 442 - 443
  • [39] LABORATORY MARKERS AND THE RISK OF DEVELOPING HIV-1 DISEASE AMONG INJECTING DRUG-USERS
    ALCABES, P
    SELWYN, PA
    DAVENNY, K
    HARTEL, D
    BUONO, D
    SCHOENBAUM, EE
    KLEIN, RS
    FRIEDLAND, GH
    AIDS, 1994, 8 (01) : 107 - 115
  • [40] BENZODIAZEPINE USE AMONG INJECTING DRUG-USERS
    SEIVEWRIGHT, N
    ADDICTION, 1994, 89 (12) : 1701 - 1703